Terahertz Imaging and Characterization Protocol for Freshly Excised Breast Cancer Tumors
April 5th, 2020
10.3K views
Freshly excised human breast cancer tumors are characterized with terahertz spectroscopy and imaging following fresh tissue handling protocols. Tissue positioning is taken into consideration to enable effective characterization while providing analysis in a timely manner for future intraoperative applications.
Overview
This protocol utilizes terahertz imaging and spectroscopy to assess surgical margins in breast tumors, aiming to reduce the necessity for secondary surgeries. The technique distinguishes between cancerous and non-cancerous tissues safely and effectively.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Medical Imaging
Background
- Terahertz imaging is a non-ionizing technique.
- It evaluates the optical properties of tissues.
- This method is applicable to various solid tumors.
- Critical steps in tissue handling are essential for success.
Purpose of Study
- To improve surgical margin assessment in breast cancer.
- To minimize the need for additional surgeries.
- To facilitate the identification of tumor margins at any depth.
Methods Used
- Terahertz imaging and spectroscopy techniques.
- Fresh tissue handling protocols.
- Stage balancing for accurate imaging.
- Use of biohazard bags for safe tissue handling.
Main Results
- Successful differentiation between cancerous and non-cancerous tissues.
- Effective imaging without physical slicing of tissue.
- Timely analysis for intraoperative applications.
- Enhanced understanding of surgical margins.
Conclusions
- Terahertz imaging is a promising tool for breast cancer surgery.
- It can significantly impact surgical outcomes.
- Further applications in other solid tumors are possible.
Frequently Asked Questions
What is terahertz imaging?
Terahertz imaging is a technique that uses terahertz radiation to visualize and differentiate between various tissue types.
How does this method improve surgical outcomes?
By accurately assessing surgical margins, it reduces the likelihood of needing additional surgeries.
Is terahertz imaging safe?
Yes, it is a non-ionizing and biologically safe method for tissue evaluation.
Can this technique be used for other types of tumors?
Yes, while developed for breast cancer, it is applicable to other solid tumors requiring margin assessment.
What are critical steps in the protocol?
Critical steps include proper tissue handling and stage balancing to ensure accurate imaging results.
What materials are needed for this protocol?
Materials include a stainless steel tray, biohazard bags, and appropriate lab tools for tissue handling.
Executive Industry Relevance
Terahertz imaging provides a non-ionizing, label-free method to assess surgical margins in solid tumors, addressing a key unmet need in oncology drug development and preclinical validation. By enabling rapid differentiation between malignant and healthy tissues based on intrinsic optical properties, the technique supports mechanistic de-risking of therapeutic candidates and improves predictive confidence in preclinical models. Its applicability to freshly excised tumors facilitates translational continuity from discovery through preclinical evaluation, reducing late-stage attrition due to inadequate target engagement or off-target effects.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of tumor heterogeneity and functional validation of targets in native tissue context without fixation artifacts.
- Operational Value: Supports rapid screening of genetically engineered models for target-dependent phenotypic changes in tumor margins.
Screening & Assay Development
- Scientific Value: Provides quantitative, label-free readouts of refractive index and absorption coefficient as biomarkers of tumor phenotype.
- Operational Value: Delivers reproducible, high-resolution imaging data suitable for assay standardization across compound screening campaigns.
Translational & Preclinical Research
- Scientific Value: Facilitates correlation of imaging phenotypes with histopathological and molecular endpoints for target validation.
- Operational Value: Enables longitudinal monitoring of tumor response in orthotopic and patient-derived xenograft models without tissue destruction.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by supporting hypothesis testing in early biology, enabling quantitative assay readouts for screening, and providing translational imaging biomarkers for preclinical continuity.
- Discovery Biology: Allows non-destructive interrogation of tumor architecture and target expression patterns in fresh tissue.
- Screening: Generates standardized, quantitative optical property maps for evaluating compound effects on tumor morphology.
- Analytics: Yields frequency-dependent absorption and refractive index metrics that enable statistical comparison across experimental conditions.
- Translational Research: Bridges in vitro findings to intact tumor phenotypes, supporting go/no-go decisions based on margin status and invasiveness.
- Enterprise Reuse: Represents a platform capability applicable across solid tumor indications, maximizing ROI on imaging infrastructure.
Operational & Enterprise Impact
- Scientific Value: Enhances target validation confidence by reducing mechanistic ambiguity in tumor-stroma interactions.
- Operational Value: Ensures reproducibility through standardized tissue handling and stage balancing protocols.
- Strategic Value: Improves risk-adjusted decision-making by providing early, objective metrics of tumor invasiveness and treatment response.
- Portfolio Impact: Supports prioritization of candidates with favorable margin modulation profiles, reducing late-stage failure risk.
Implementation Considerations
- Requires expertise in terahertz optics, tissue handling, and spectroscopic data analysis.
- Depends on access to terahertz time-domain spectroscopy systems with scanning stages and polystyrene sample platforms.
- Necessitates standardized protocols for tumor preparation, including fluid removal and air bubble minimization, to ensure data quality.
- Involves adaptation considerations for varying tumor sizes, densities, and stromal compositions across model systems.
- Includes practical limitations related to sample dehydration over time and signal attenuation in highly hydrated or necrotic tissues.
Biopharma FAQs
Why is reference signal acquisition critical for terahertz imaging?
Recording a reference signal from the polystyrene plate enables subtraction of system artifacts and isolation of tissue-specific terahertz transmission and reflection characteristics, which is essential for accurate extraction of refractive index and absorption coefficient values.
How does stage balancing affect measurement accuracy in terahertz spectroscopy?
Proper leveling of the scanning stage using the A and B axes ensures consistent sample-to-sensor alignment, preventing signal drift and artifacts that could distort time-domain pulses and compromise the quantification of tissue optical properties.
What quantitative outputs enable differentiation between cancerous and healthy tissues?
The protocol yields frequency-dependent absorption coefficient and refractive index maps, where cancerous regions demonstrate higher absorption and distinct refractive index trends compared to adipose tissue, enabling label-free phenotypic discrimination.
Why are replication requirements important for cross-functional collaboration in imaging studies?
Replication across multiple tissue samples and imaging sessions ensures reliability of terahertz-derived metrics, allowing pathology, oncology, and imaging teams to align on objective thresholds for tumor margin assessment and treatment response evaluation.
What statistical analysis capabilities are needed before implementing terahertz imaging in preclinical workflows?
Implementation requires capability for pixel-wise statistical comparison of absorption and refractive index values, including t-tests or ANOVA across tissue regions, to support automated segmentation and objective classification of tumor versus stroma.
